Page last updated: 2024-11-04

sobuzoxane and Lymphoma

sobuzoxane has been researched along with Lymphoma in 3 studies

sobuzoxane: used in treatment of leukemia L1210

Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.

Research Excerpts

ExcerptRelevanceReference
" The patient achieved a complete response (CR) after treatment with oral low-dose sobuzoxane and etoposide combined with rituximab."5.40[Successful treatment with oral low-dose sobuzoxane and etoposide combined with rituximab in an elderly patient with HHV-8-negative primary effusion lymphoma-like lymphoma]. ( Abe, Y; Choi, I; Haji, S; Kiyasu, J; Ohshima, K; Suehiro, Y; Toyoda, K; Tsuda, M; Uike, N, 2014)
"Sobuzoxane (MST-16) is an analogue of ICRF-159 which was once evaluated on the clinical efficacies in England."2.39[A novel antitumor agent, sobuzoxane (MST-16)]. ( Tsukagoshi, S, 1994)
" The patient achieved a complete response (CR) after treatment with oral low-dose sobuzoxane and etoposide combined with rituximab."1.40[Successful treatment with oral low-dose sobuzoxane and etoposide combined with rituximab in an elderly patient with HHV-8-negative primary effusion lymphoma-like lymphoma]. ( Abe, Y; Choi, I; Haji, S; Kiyasu, J; Ohshima, K; Suehiro, Y; Toyoda, K; Tsuda, M; Uike, N, 2014)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Ohmoto, A1
Fuji, S1
Toyoda, K1
Abe, Y1
Tsuda, M1
Haji, S1
Choi, I1
Suehiro, Y1
Kiyasu, J1
Ohshima, K1
Uike, N1
Tsukagoshi, S1

Reviews

1 review available for sobuzoxane and Lymphoma

ArticleYear
[A novel antitumor agent, sobuzoxane (MST-16)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:7

    Topics: Animals; Antineoplastic Agents; Clinical Trials, Phase II as Topic; Humans; Leukemia, Experimental;

1994

Other Studies

2 other studies available for sobuzoxane and Lymphoma

ArticleYear
Clinical feasibility of oral low-dose etoposide and sobuzoxane for conventional chemotherapy-intolerant lymphoma patients.
    Expert review of anticancer therapy, 2021, Volume: 21, Issue:7

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Feasibility Studies

2021
[Successful treatment with oral low-dose sobuzoxane and etoposide combined with rituximab in an elderly patient with HHV-8-negative primary effusion lymphoma-like lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Herpesvirus 8, Human; Humans; Lymph

2014